Skip to main content

Table 1 Patients characteristics (n = 6)

From: Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study

Characteristic

Number patients (%)

Age (years)

 

     40-49

1 (16.7)

     50-59

4 (66.7)

     60-69

1 (16.7)

Race

 

     African-American

1(16.7)

     Caucasian

5 (83.3)

GOG Performance Status

 

     0

5 (83.3)

     1

0 (0.0)

     2

1 (16.7)

Ovarian cancer sub-type

 

     Endometrioid

1 (16.7)

     Mixed epithelial carcinoma

1 (16.7)

     Serous adenocarcinoma

4 (66.7)

Prior therapy

 

     Chemotherapy

6 (100)

          Median number prior regimens (range)

1(1)

     Surgery

6 (100)

  1. GOG = Gynecologic Oncology Group.